A $36.3M Series b funding round has been secured by M Ventures, the corporate venture capital fund of Merck KgaA, Darmstadt, Germany. This latest capital raise reinforces its position as a dedicated investor in high-growth sectors.
As a corporate venture capital arm, M Ventures focuses its investments across Biotechnology, specifically targeting Healthcare therapeutics and Life Science tools. It also backs companies in the Technology space, with verticals spanning electronics, frontier technologies, and sustainability.
